Cargando…
EDEUS, a Real-Life Study on the Users of Phosphodiesterase Type 5 Inhibitors: Prevalence, Perceptions, and Health Care-Seeking Behavior Among European Men With a Focus on 2nd-Generation Avanafil
INTRODUCTION: Erectile dysfunction (ED) is a multidimensional disorder with an estimated prevalence of 1% to 10% in men younger than 40 years and up to 100% in men in their 70s and 80s. AIM: To evaluate the real-life characteristics and unmet needs of men with ED, its impact on well-being, and treat...
Autores principales: | Corona, Giovanni, Maggi, Mario, Jannini, Emmanuele A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815971/ https://www.ncbi.nlm.nih.gov/pubmed/29275958 http://dx.doi.org/10.1016/j.esxm.2017.10.003 |
Ejemplares similares
-
Influence of Alcohol on Phosphodiesterase 5 inhibitors Use in Middle- to Old-Aged Men: A Comparative Study of Adverse Events
por: Kim, Jong Nyeong, et al.
Publicado: (2019) -
Oral L-citrulline and Transresveratrol Supplementation Improves Erectile Function in Men With Phosphodiesterase 5 Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Crossover Pilot Study
por: Shirai, Masato, et al.
Publicado: (2018) -
Toward a new ‘EPOCH’: optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction
por: Sadovsky, R, et al.
Publicado: (2009) -
Erectile Dysfunction is Predictive Symptom for Poor Semen in Newlywed Men in Japan
por: Tsujimura, Akira, et al.
Publicado: (2019) -
Deterioration of Chronotropic Responses and Heart Rate Recovery Indices in Men With Erectile Dysfunction
por: Kucukdurmaz, Faruk, et al.
Publicado: (2017)